Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-10-24 4:08 pm Purchase | 13G | Monopar Therapeutics MNPR | TANG CAPITAL MANAGEMENT LLC | 200,000 5.1% | 200,000 (New Position) | View |
2024-10-08 4:20 pm Purchase | 13D | KEZAR LIFE SCIENCES INC KZR | TANG CAPITAL MANAGEMENT LLC | 7,200,000 9.9% | 7,200,000 (New Position) | View |
2024-09-30 09:00 am Purchase | 13G | ITEOS THERAPEUTICS INC. ITOS | TANG CAPITAL MANAGEMENT LLC | 2,407,800 6.6% | 2,407,800 (New Position) | View |
2024-09-18 4:26 pm Purchase | 13D | SINGULAR GENOMICS SYS INC OMIC | TANG CAPITAL MANAGEMENT LLC | 372,000 14.9% | 372,000 (New Position) | View |
2024-09-12 4:10 pm Purchase | 13D | AURINIA PHARMACEUTICALS INC AUPH | TANG CAPITAL MANAGEMENT LLC | 7,229,500 5.1% | 7,229,500 (New Position) | View |
2022-04-21 4:00 pm Purchase | 13G | Inspirato Inc ISPO | TANG CAPITAL MANAGEMENT LLC | 2,432,600 5% | 2,432,600 (New Position) | View |
2022-04-21 4:00 pm Purchase | 13G | ASLAN PHARMACEUTICALS LTD SPON ASLN | TANG CAPITAL MANAGEMENT LLC | 18,796,125 5.4% | 18,796,125 (New Position) | View |